GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Enterprise Value

AroCell AB (OSTO:AROC) Enterprise Value : kr48.33 Mil (As of May. 04, 2024)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AroCell AB's Enterprise Value is kr48.33 Mil. AroCell AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-59.29 Mil. Therefore, AroCell AB's EV-to-EBIT ratio for today is -0.82.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, AroCell AB's Enterprise Value is kr48.33 Mil. AroCell AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr-59.29 Mil. Therefore, AroCell AB's EV-to-EBITDA ratio for today is -0.82.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, AroCell AB's Enterprise Value is kr48.33 Mil. AroCell AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr43.04 Mil. Therefore, AroCell AB's EV-to-Revenue ratio for today is 1.12.


AroCell AB Enterprise Value Historical Data

The historical data trend for AroCell AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB Enterprise Value Chart

AroCell AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.16 135.10 94.41 77.63 49.94

AroCell AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.63 90.24 69.15 65.05 49.94

Competitive Comparison of AroCell AB's Enterprise Value

For the Diagnostics & Research subindustry, AroCell AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's Enterprise Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where AroCell AB's Enterprise Value falls into.



AroCell AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

AroCell AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

AroCell AB's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB  (OSTO:AROC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

AroCell AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=48.332/-59.286
=-0.82

AroCell AB's current Enterprise Value is kr48.33 Mil.
AroCell AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-59.29 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

AroCell AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=48.332/-59.286
=-0.82

AroCell AB's current Enterprise Value is kr48.33 Mil.
AroCell AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-59.29 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

AroCell AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=48.332/43.039
=1.12

AroCell AB's current Enterprise Value is kr48.33 Mil.
AroCell AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr43.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of AroCell AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock Increases Quarterly Cash Dividend

By Stock market mentor Stock market mentor 01-26-2023

Archrock (AROC): A Deep Dive into Its Overvaluation

By GuruFocus Research 09-27-2023

Archrock Announces Timing for Second Quarter 2022 Results

By PurpleRose PurpleRose 07-18-2022

Archrock Announces Timing for Fourth Quarter 2021 Results

By GuruFocusNews GuruFocusNews 02-10-2022

Archrock Announces Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 04-28-2022

Archrock to Partner with ECOTEC on Methane Emissions Management

By GuruFocusNews GuruFocusNews 04-25-2022

Archrock Increases Quarterly Cash Dividend

By Marketwired 07-27-2023

Archrock Announces Quarterly Cash Dividend

By Marketwired 10-26-2023